Brief: Relief Therapeutics Says NRX Pharmaceuticals Announced Additional Results From Aviptadil U.S. Expanded Access Protocol

MindMaze Therapeutics Holding SA

16/06/2021 06:05

June 16 (Reuters) - RELIEF THERAPEUTICS HOLDING SA  RLFB.S :
    * RELIEF THERAPEUTICS REPORTS THAT COLLABORATION PARTNER,
NRX
PHARMACEUTICALS, HAS ANNOUNCED ADDITIONAL RESULTS FROM THE
AVIPTADIL U.S. EXPANDED ACCESS PROTOCOL FOR PATIENTS WITH
CRITICAL COVID-19

Source text for Eikon:  ID:nEQ1kVvWfa 
Further company coverage:  RLFB.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))